{"id":7799,"date":"2025-05-31T22:53:38","date_gmt":"2025-05-31T22:53:38","guid":{"rendered":"https:\/\/thedailyglow.fun\/?p=7799"},"modified":"2025-05-31T22:53:38","modified_gmt":"2025-05-31T22:53:38","slug":"fda-issues-recall-for-popular-medication-due-to-potential-cancer-risk","status":"publish","type":"post","link":"https:\/\/thedailyglow.fun\/?p=7799","title":{"rendered":"FDA Issues Recall for Popular Medication Due to Potential Cancer Risk"},"content":{"rendered":"<p>In a significant development affecting countless patients, the U.S. Food and Drug Administration (FDA) has issued a recall for certain batches of Duloxetine, a widely prescribed antidepressant, due to the presence of a potentially cancer-causing impurity. This action underscores growing concerns about nitrosamine contaminants in pharmaceuticals.<\/p>\n<p>What Is Duloxetine?<br \/>\nDuloxetine, known by brand names such as Cymbalta, Drizalma Sprinkle, and Irenka, is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly prescribed to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, diabetic neuropathy, and chronic musculoskeletal pain. Its dual-action mechanism enhances the levels of serotonin and norepinephrine in the brain, helping to alleviate both emotional and physical symptoms.<\/p>\n<p>The Recall Details<br \/>\nThe recall, initiated by Towa Pharmaceutical Europe, pertains to specific lots of delayed-release Duloxetine capsules found to contain N-nitroso-duloxetine, a nitrosamine impurity.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a significant development affecting countless patients, the U.S. Food and Drug Administration (FDA) has issued a recall for certain batches of Duloxetine, a widely prescribed antidepressant,&#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-7799","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/posts\/7799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7799"}],"version-history":[{"count":1,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/posts\/7799\/revisions"}],"predecessor-version":[{"id":7800,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=\/wp\/v2\/posts\/7799\/revisions\/7800"}],"wp:attachment":[{"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thedailyglow.fun\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}